Medpace Holdings, Inc.

Medpace Holdings, Inc.

MEDP·NASDAQ

$450.81

+1.2%
HealthcareMedical - Diagnostics & Research

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.

At a Glance

Live Snapshot
Market Cap$12.88B
EPS15.6400
P/E Ratio28.82
Earnings Date07/20/2026

medp

Inventory

Last Annual Value

0.00

3-Year CAGR

%

5-Year CAGR

%

10-Year CAGR

%

Medpace Holdings, Inc.

Medpace Holdings, Inc. Competitors Analysis of Inventory

MEDP · NASDAQ
CompanyInventory
CAGR 3Y
CAGR 5Y
CAGR 10Y
0.00
N/AN/AN/A 
0.00
N/AN/AN/A
TEM logo
Tempus AI, Inc.
NASDAQ:TEM
51.72M
21.5%17.7%N/A
572.37M
3.5%10.0%8.1%
189.00M
-0.2%-1.9%8.7%
ILMN logo
Illumina, Inc.
NASDAQ:ILMN
564.00M
-1.3%5.5%6.5%
443.90M
0.7%3.2%8.3%
348.00M
-5.4%-1.9%0.7%
HOLX logo
Hologic, Inc.
NASDAQ:HOLX
679.40M
3.2%6.3%9.5%
Medpace Holdings, Inc.

Medpace Holdings, Inc. Fair Value Envelope

MEDP · NASDAQ

Our analysis suggests that MEDP has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $450.815, this represents a potential HIDDEN relative to our calculated worth for Medpace Holdings, Inc..

Intrinsic Value
Current Price: $450.815